Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Launching in 2022, its availability will be expanded to the global market
EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
The students can interact with resident doctors and graduates of SGU
Cortrophin gel is purified corticotropin (ACTH), an important treatment option for patients struggling with certain chronic autoimmune disorders. It acquired the NDA for cortrophin gel from Merck & Co. in 2016
The NFI is published to promote the rational use of medicines in the country.
Subscribe To Our Newsletter & Stay Updated
